Comparing Melanoma Invasiveness in Dermatologist- versus Patient-Detected Lesions: A Retrospective Chart Review
- PMID: 22848838
- PMCID: PMC3405671
- DOI: 10.1155/2012/187963
Comparing Melanoma Invasiveness in Dermatologist- versus Patient-Detected Lesions: A Retrospective Chart Review
Abstract
This study examined whether patient-identified melanomas were more advanced than dermatologist-identified tumors at routine clinic visits, and whether a personal or family history of skin cancer was associated with patterns of detection. A retrospective chart review was performed on melanoma patients (N = 201) in a private dermatology clinic. Variables included age, gender, pattern of detection (i.e., patient or a board certified dermatologist), personal or family history of skin cancer, skin type, and previous sun exposure, as well as tumor location and severity. Dermatologist-diagnosed melanomas were less invasive (P < 0.0005), and more likely present on the chest, back, and legs (P < 0.01). Conversely, patient-identified lesions were more likely to occur on the face, neck and scalp, be associated with younger patients, and a family history of melanoma, but not other types of skin cancer (P < 0.01). In a post-hoc analysis examining these factors as predictors of tumor invasiveness, only diagnostic source was significant. Specifically, dermatologist-identified tumors were significantly less invasive than patient-identified tumors. Although age, family history, and tumor location played roles in the early detection of melanomas, the most important factor was diagnostic source. Thus, board-certified dermatologists play a key role in the early detection of malignant melanoma.
Similar articles
-
Melanoma screening by means of complete skin exams for all patients in a dermatology practice reduces the thickness of primary melanomas at diagnosis.J Clin Aesthet Dermatol. 2014 Aug;7(8):18-22. J Clin Aesthet Dermatol. 2014. PMID: 25161756 Free PMC article.
-
Routine dermatologist-performed full-body skin examination and early melanoma detection.Arch Dermatol. 2009 Aug;145(8):873-6. doi: 10.1001/archdermatol.2009.137. Arch Dermatol. 2009. PMID: 19687416
-
Melanoma depth in patients with an established dermatologist.J Am Acad Dermatol. 2014 May;70(5):841-6. doi: 10.1016/j.jaad.2013.10.060. Epub 2014 Mar 12. J Am Acad Dermatol. 2014. PMID: 24629997
-
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67. Acta Dermatovenerol Croat. 2018. PMID: 29782304 Review.
-
Changing trends in melanoma treatment and the expanding role of the dermatologist.Dermatol Clin. 1991 Oct;9(4):657-67. Dermatol Clin. 1991. PMID: 1934641 Review.
Cited by
-
Development of a Prediction Model for Patients at Risk of Incidental Skin Cancer: A Multicentre Prospective Study.Acta Derm Venereol. 2021 Jul 13;101(7):adv00498. doi: 10.2340/00015555-3862. Acta Derm Venereol. 2021. PMID: 34219175 Free PMC article.
References
-
- U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine. 2009;150(3):188–193. - PubMed
-
- Centers for Disease Control and Prevention. Skin cancer: basic information. 2009, http://www.cdc.gov/cancer/skin/basic_info/
-
- Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma. Journal of the American Academy of Dermatology. 1998;38(5):669–680. - PubMed
-
- Alexandrescu DT. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Dermatology Online Journal. 2009;15(11):1–15. - PubMed
-
- Seidler AM, Pennie ML, Veledar E, Culler SD, Chen SC. Economic burden of melanoma in the elderly population. Archives of Dermatology. 2010;146(3):249–256. - PubMed
LinkOut - more resources
Full Text Sources